statistiche ricercatore

Continente	#
NA - Nord America	1.657
EU - Europa	650
AS - Asia	568
SA - Sud America	89
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	1
Totale	2.988

Nazione	#
US - Stati Uniti d'America	1.642
GB - Regno Unito	231
SG - Singapore	194
CN - Cina	133
IT - Italia	122
VN - Vietnam	81
BR - Brasile	63
DE - Germania	60
SE - Svezia	57
HK - Hong Kong	50
FI - Finlandia	44
FR - Francia	33
UA - Ucraina	27
RU - Federazione Russa	26
IN - India	22
TR - Turchia	22
BD - Bangladesh	15
KR - Corea	14
BE - Belgio	10
ID - Indonesia	9
AR - Argentina	8
BG - Bulgaria	8
CA - Canada	8
SI - Slovenia	7
PK - Pakistan	6
ZA - Sudafrica	6
CL - Cile	5
CZ - Repubblica Ceca	5
IQ - Iraq	5
KE - Kenya	5
MX - Messico	5
CO - Colombia	4
ES - Italia	4
EC - Ecuador	3
JP - Giappone	3
MY - Malesia	3
PH - Filippine	3
PL - Polonia	3
AT - Austria	2
IE - Irlanda	2
MA - Marocco	2
PE - Perù	2
RO - Romania	2
SA - Arabia Saudita	2
TN - Tunisia	2
UY - Uruguay	2
XK - ???statistics.table.value.countryCode.XK???	2
AU - Australia	1
BO - Bolivia	1
CD - Congo	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
GE - Georgia	1
GH - Ghana	1
GR - Grecia	1
HU - Ungheria	1
IL - Israele	1
IS - Islanda	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
MD - Moldavia	1
NL - Olanda	1
OM - Oman	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TH - Thailandia	1
VE - Venezuela	1
Totale	2.988

Nome	#
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms	556
NF-YA splice variants have different roles on muscle differentiation	408
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing	393
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy	351
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa	347
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group	342
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study	331
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA	278
Totale	3.006

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	41	0	0	0	0	0	0	0	0	0	0	20	21
2021/2022	191	6	16	28	13	10	13	12	11	19	13	30	20
2022/2023	213	31	27	18	18	21	30	7	21	24	0	6	10
2023/2024	147	7	4	9	8	25	26	16	16	0	5	9	22
2024/2025	394	14	4	16	25	66	57	28	30	36	20	43	55
2025/2026	873	60	46	67	81	182	50	142	49	82	87	27	0
Totale													3.006